| Bioactivity | Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2]. | ||||||||||||
| Invitro | The antimalarial activity of Artemotil is test in vitro against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum parasites. The mean 50% inhibitory concentration (IC50) for Artemotil is 1.61 nM (range 1.57-1.92 nM). Artemotil is approximately 2.5-fold more potent than artemisinin[1]. | ||||||||||||
| Name | Artemotil | ||||||||||||
| CAS | 75887-54-6 | ||||||||||||
| Formula | C17H28O5 | ||||||||||||
| Molar Mass | 312.40 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Artemotil
CAS: 75887-54-6 F: C17H28O5 W: 312.40
Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum mala
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.